| Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous … S Balachandar, TJ Graves, A Shimonty, K Kerr, J Kilner, S Xiao, R Slade, ... American Journal of Medical Genetics Part A 188 (3), 959-964, 2022 | 29 | 2022 |
| A scoping review and proposed workflow for multi-omic rare disease research K Kerr, H McAneney, LJ Smyth, C Bailie, S McKee, AJ McKnight Orphanet journal of rare diseases 15, 1-18, 2020 | 28 | 2020 |
| Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study LJ Smyth, J Kilner, V Nair, H Liu, E Brennan, K Kerr, N Sandholm, J Cole, ... Clinical epigenetics 13 (1), 99, 2021 | 26 | 2021 |
| Differential methylation as a diagnostic biomarker of rare renal diseases: a systematic review K Kerr, H McAneney, C Flanagan, AP Maxwell, AJ McKnight BMC nephrology 20 (1), 1-9, 2019 | 9 | 2019 |
| Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease LJ Smyth, EH Dahlström, A Syreeni, K Kerr, J Kilner, R Doyle, E Brennan, ... Nature Communications 13 (1), 7891, 2022 | 5 | 2022 |
| Criteria to define rare diseases and orphan drugs: a systematic review protocol GM Abozaid, K Kerr, A McKnight, HA Al-Omar BMJ open 12 (7), e062126, 2022 | 5 | 2022 |
| Communication strategies for rare cancers: a systematic review protocol C Bell, K Kerr, K Moore, C McShane, L Anderson, AJ McKnight, ... Systematic reviews 8 (1), 1-6, 2019 | 5 | 2019 |
| Systematic review of differential methylation in rare ophthalmic diseases K Kerr, H McAneney, L Smyth, C Flanagan, J Silvestri, MA Nesbitt, ... BMJ open ophthalmology 4 (1), e000342, 2019 | 4 | 2019 |
| Protocol for a scoping review of multi-omic analysis for rare diseases K Kerr, H McAneney, AJ McKnight BMJ open 9 (5), e026278, 2019 | 4 | 2019 |
| Promoting and establishing an effective campus-wide academic advising system KE Kerr The University of Nebraska-Lincoln, 2018 | 4 | 2018 |
| Longitudinal Epigenome-Wide Analysis of Kidney Transplant Recipients Pretransplant and Posttransplant LJ Smyth, KR Kerr, J Kilner, ÁE McGill, AP Maxwell, AJ McKnight Kidney International Reports 8 (2), 330-340, 2023 | 2 | 2023 |
| Genetic Strategies to Understand Human Diabetic Nephropathy: Wet-Lab Approaches LJ Smyth, K Kerr, S Duffy, J Kilner, AJ McKnight Diabetic Nephropathy: Methods and Protocols, 205-240, 2020 | 2 | 2020 |
| Differential methylation in rare ophthalmic disorders: a systematic review protocol K Kerr, H McAneney, AJ McKnight Systematic Reviews 8, 1-4, 2019 | 2 | 2019 |
| Novel GDF2 loss of function variant in a family with HHT and PAVMs expands the phenotype associated with BMP9 dysfunction S Balachandar, T Graves, A Shimonty, S Xiao, R Slade, M Sroya, ... D25. O BRAVE NEW WORLD! OMICS, SYSTEM BIOLOGY, AND NEW MOLECULAR MECHANISMS …, 2020 | 1 | 2020 |
| Perspectives on a Ni rare disease registry J McMullan, A Crowe, K Kerr, C Bailie, H McAneney, F McLaughlin, ... | 1 | 2020 |
| Genetic Strategies to Understand Human Diabetic Nephropathy: In Silico Strategies for Molecular Data—Association Studies M Canadas-Garre, LJ Smyth, K Anderson, K Kerr, AJ McKnight Diabetic Nephropathy: Methods and Protocols, 241-275, 2020 | 1 | 2020 |
| HPR173 Criteria to Define Rare Diseases and Orphan Drugs: Systematic Literature Review G Abozaid, K Kerr, A McKnight, H Al-Omar Value in Health 25 (12), S264, 2022 | | 2022 |
| HPR2 Criteria to Define Rare Diseases and Orphan Drugs Systematic Literature Review G Abozaid, K Kerr, A McKnight, H Al-Omar Value in Health 25 (12), S232, 2022 | | 2022 |
| A Formative Study of the Implementation of Whole Genome Sequencing in Northern Ireland K Kerr, C McKenna, S Heggarty, C Bailie, J McMullan, A Crowe, J Kilner, ... Genes 13 (7), 1104, 2022 | | 2022 |
| Lessons learned about whole genome sequencing from Northern Ireland's participation in the 100,000 Genomes Project K Kerr, S Mckee, C Flanagan, AJ McKnight IRISH JOURNAL OF MEDICAL SCIENCE 191 (SUPPL 3), S66-S66, 2022 | | 2022 |
